Denis Vetter

882 total citations
11 papers, 678 citations indexed

About

Denis Vetter is a scholar working on Hepatology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Denis Vetter has authored 11 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 6 papers in Epidemiology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Denis Vetter's work include Hepatitis B Virus Studies (4 papers), Liver Disease and Transplantation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Denis Vetter is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Liver Disease and Transplantation (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). Denis Vetter collaborates with scholars based in France, United States and Canada. Denis Vetter's co-authors include Michel Doffoël, Jean-Jacques Wenger, Jean–Pierre Bronowicki, P Boissel, Karim Boudjéma, Marialuisa Partisani, Jean-Marie Lang, Marie‐Paule Schmitt, Marie-Josée Wendling and P. Meyer and has published in prestigious journals such as Hepatology, Cancer and The Journal of Infectious Diseases.

In The Last Decade

Denis Vetter

11 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Vetter France 10 553 437 104 103 71 11 678
R. Bottelli Italy 10 544 1.0× 435 1.0× 82 0.8× 31 0.3× 39 0.5× 17 648
Leonieke M. M. Wolters Netherlands 14 362 0.7× 425 1.0× 159 1.5× 54 0.5× 103 1.5× 20 673
P. Chossegros France 12 805 1.5× 761 1.7× 75 0.7× 55 0.5× 34 0.5× 42 1.0k
M.L. Ribero Italy 19 940 1.7× 934 2.1× 220 2.1× 125 1.2× 128 1.8× 35 1.3k
Jennifer E. Layden‐Almer United States 15 709 1.3× 653 1.5× 67 0.6× 47 0.5× 11 0.2× 16 903
Malte Heeg Germany 11 239 0.4× 252 0.6× 52 0.5× 43 0.4× 27 0.4× 16 746
S. Hadziyannis Greece 11 449 0.8× 406 0.9× 52 0.5× 50 0.5× 51 0.7× 26 633
M Duffaut France 16 971 1.8× 827 1.9× 97 0.9× 33 0.3× 30 0.4× 49 1.2k
Yoshiyuki Suzuki Japan 9 797 1.4× 784 1.8× 210 2.0× 38 0.4× 104 1.5× 20 1.0k
Enrique Martínez United States 18 445 0.8× 335 0.8× 267 2.6× 24 0.2× 50 0.7× 35 698

Countries citing papers authored by Denis Vetter

Since Specialization
Citations

This map shows the geographic impact of Denis Vetter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Vetter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Vetter more than expected).

Fields of papers citing papers by Denis Vetter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Vetter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Vetter. The network helps show where Denis Vetter may publish in the future.

Co-authorship network of co-authors of Denis Vetter

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Vetter. A scholar is included among the top collaborators of Denis Vetter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Vetter. Denis Vetter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Marcellin, Patrick, Yves Horsmans, Frederik Nevens, et al.. (2007). Phase 2 study of the combination of merimepodib with peginterferon-α2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C. Journal of Hepatology. 47(4). 476–483. 20 indexed citations
2.
Duffour, Jacqueline, Olivier Bouché, Philippe Rougier, et al.. (2006). Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).. PubMed. 26(5B). 3877–83. 10 indexed citations
3.
Rey, David, Marialuisa Partisani, Marie‐Paule Schmitt, et al.. (2000). Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine. 18(13). 1161–1165. 175 indexed citations
4.
Bronowicki, Jean–Pierre, et al.. (1997). Lymphocyte Reactivity to Hepatitis C Virus (HCV) Antigens Shows Evidence for Exposure to HCV in HCV‐Seronegative Spouses of HCV‐Infected Patients. The Journal of Infectious Diseases. 176(2). 518–522. 50 indexed citations
5.
Bronowicki, Jean–Pierre, Karim Boudjéma, Laurence Choné, et al.. (1996). Comparison of resection, liver transplantation and transcatheter oily chemoembolization in treatment of hepatocellular carcinoma. Journal of Hepatology. 24(3). 293–300. 85 indexed citations
6.
Bronowicki, Jean–Pierre, Denis Vetter, Karim Boudjéma, et al.. (1994). Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year Study of 127 French Patients. Cancer. 74(1). 16–24. 135 indexed citations
7.
Évrard, Serge, et al.. (1993). Massive gas spread through a duodenal perforation after endoscopic sphincterotomy. Gastrointestinal Endoscopy. 39(6). 817–818. 8 indexed citations
8.
9.
Trinchet, Jean–Claude, Beverley Balkau, Renée E. Poupon, et al.. (1992). Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial. Hepatology. 15(1). 76–81. 52 indexed citations
10.
11.
Doffoël, M, M. M. Tongio, Jean‐Pierre Gut, et al.. (1986). Relationships between 34 HLA-A, HLA-B and HLA-DR antigens and three serological markers of viral infections in alcoholic cirrhosis. Hepatology. 6(3). 457–463. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Bottelli Breakdown of academic impact, for papers by Leonieke M. M. Wolters Breakdown of academic impact, for papers by P. Chossegros Breakdown of academic impact, for papers by M.L. Ribero Breakdown of academic impact, for papers by Jennifer E. Layden‐Almer Breakdown of academic impact, for papers by Malte Heeg Breakdown of academic impact, for papers by S. Hadziyannis Breakdown of academic impact, for papers by M Duffaut Breakdown of academic impact, for papers by Yoshiyuki Suzuki Breakdown of academic impact, for papers by Enrique Martínez
Rankless by CCL
2026